Status:
TERMINATED
Aerobic Fitness in Overweight and Obese Individuals
Lead Sponsor:
Vedic Lifesciences Pvt. Ltd.
Conditions:
Healthy
Eligibility:
MALE
18-35 years
Phase:
NA
Brief Summary
Oxyjun is known for improving cardiovascular endurance. Overweight and obese individuals are at increased risk of cardiovascular complications. To lower the risk, these individuals need to remain phys...
Eligibility Criteria
Inclusion
- Body Mass Index ≥ 25 - ≤ 34.9 kg/m2.
- Waist Circumference ≥ 80 cms.
- Non-smoker.
- BP ≤ 140/90 mm Hg
- FBS ≤ 125 mg/dl
- Hb ≥ 11 g/ dl
- Can abstain from strenuous exercise and alcohol for at least 48 hours.
- Can abstain from caffeine for at least 24 hours.
Exclusion
- Participants with history of regular (≥2 times a week) structured exercise (gym, walking, yoga, etc).
- Inter-arm blood pressure is ≥10 mm Hg.
- Known cases of type II Diabetes Mellitus.
- Known cases of hypertension with or without anti-hypertensive medication.
- Visual or balance problems, or who cannot walk on a treadmill without using the handrails.
Key Trial Info
Start Date :
January 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 28 2020
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT03854786
Start Date
January 3 2020
End Date
May 28 2020
Last Update
January 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vedic Lifesciences Pvt. Ltd
Mumbai, Opp Infinity Mall, India, 400053